Total Visits

Views
Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment15

Select a period of time:

Views

Views
November 20231
December 20230
January 20246
February 20241
March 20240
April 20241
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views
Boardman6
Ashburn2